Concerns are mounting in the pharmaceutical sector as industry leaders warn of imminent price escalations. Mankind Pharma Ltd., a leading drugmaker, cautioned that medicine prices in India could rise within the next month due to severe energy supply shocks stemming from geopolitical conflicts.
Arjun Juneja, the Chief Operating Officer of the New Delhi-based firm, stated that while the sector initially benefited from older inventory reserves, the full impact of the cost crunch is now unavoidable. He advised that the price hikes are fundamentally linked to global disruptions in oil and petrochemical supplies.
Rising Input Costs Drive Pharma Price Hikes
Juneja warned that the full effects of the energy shortages would become apparent within the next 15 to 20 days, or over the coming month. These shortages specifically affect critical petroleum-related products needed for manufacturing APIs and pharmaceutical formulations.He explained that increased input costs, primarily driven by dwindling access to energy and petrochemical raw materials, are poised to trigger substantial inflationary pressures across the entire pharmaceutical industry.
Many essential medicines rely heavily on derivatives of crude oil. The industry utilizes petroleum-based chemicals as crucial raw materials to manufacture various drugs, solvents, and medicinal products.
The Link Between Crude Oil and Drug Manufacturing
The pharmaceutical process is intimately linked to petrochemicals. Crude oil is refined into petrochemicals such as benzene, toluene, ethylene, and propylene. These refined substances are foundational components used in the creation of active pharmaceutical ingredients (APIs) and other specialized medical products.The dependence extends beyond APIs. Medical plastics, which are vital for items like syringes, IV bags, and pill packaging, are also petrochemical derivatives, adding another layer of cost vulnerability to the supply chain.
Globally, the price fluctuation is severe. International crude oil prices surged dramatically, jumping from around $70 per barrel before the Iran war outbreak in late February to as much as $120 per barrel. This spike is attributable to the blockade of the Strait of Hormuz and attacks on oil and gas infrastructure across the Gulf region.
Long-Term Supply Chain Outlook Remains Challenging
The current supply disruption is projected to be long-lasting. Juneja stated that the supply situation is unlikely to normalize quickly for the industry.He cautioned that stabilizing supply chains could take anywhere between six months to a full year. This extended timeframe hinges critically on how geopolitical tensions evolve and how global energy markets successfully adjust.
The gravity of the situation has already prompted government action, with authorities last month diverting gas supplies from industrial units to households to cushion the consumer shock. Given the drastic nature of potential price increases, such a scenario could trigger significant regulatory intervention.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.